05/29/2026
NEW: The Office of Inspector General (OIG) just made it harder to ignore a compliance risk that's been flying under the radar in the medical device industry. 🩼
In a new Advisory Opinion, the OIG found that one company's royalty payment arrangement with physician consultants crossed the line under the Anti-Kickback Statute, and the reasoning has broader implications worth paying attention to.
In their latest for The National Law Review, attorneys Edgar Bueno and Matt Wilmot break down what the opinion says, why it matters, and what medical device companies and physician consultants should be doing about it now.
READ THEIR FULL ANALYSIS HERE: https://shorturl.at/QIOsp